Director, Global Market Access

Role: Lead global market access and pricing strategy for Alnylam’s Rare Disease portfolio and pipeline assets, ensuring consistent access across markets. Responsibilities: develop and communicate strategic access plans, collaborate with cross-functional teams on payer segmentation, contracting, and value propositions, and manage the Global Pricing System. Serve as a primary contact for pricing strategy guidance, support evidence generation to justify brand value, and influence competitive positioning through innovative market access tactics. Qualifications: Bachelor's degree required; MBA, MPH, PharmD, or health economics/Outcomes Research preferred. Over 10 years of experience in commercial market access, with 5+ years in rare disease, including US, EU, and emerging markets. Skills include strategic problem-solving, cross-functional leadership, excellent communication, and data-driven decision-making. High-value specifics: focus on rare diseases, specialty products, and markets with complex reimbursement landscapes; experience with launch pricing, contracting, and regulatory considerations. Collaboration with global/regional teams, external partners, and senior leadership is integral. Location: Not specified.